EW
USDEdwards Lifesciences Corporation Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$83.050
Máximo
$84.830
Mínimo
$82.890
Volume
2.64M
Fundamentos da empresa
Capitalização de mercado
49.4B
Setor
Dispositivos médicos
País
United States
Estatísticas de negociação
Volume médio
4.58M
Bolsa de valores
NYQ
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
Truist Securities Maintains Hold on Edwards Lifesciences, Raises Price Target to $90
Truist Securities analyst Richard Newitter maintains Edwards Lifesciences with a Hold and raises the price target from $87 to $90.
Barclays Maintains Overweight on Edwards Lifesciences, Raises Price Target to $99
Barclays analyst Matt Miksic maintains Edwards Lifesciences with a Overweight and raises the price target from $95 to $99.
Citigroup Maintains Buy on Edwards Lifesciences, Raises Price Target to $96
Citigroup analyst Joanne Wuensch maintains Edwards Lifesciences with a Buy and raises the price target from $95 to $96.
JP Morgan Maintains Neutral on Edwards Lifesciences, Raises Price Target to $90
JP Morgan analyst Robbie Marcus maintains Edwards Lifesciences with a Neutral and raises the price target from $85 to $90.
Goldman Sachs Maintains Buy on Edwards Lifesciences, Raises Price Target to $104
Goldman Sachs analyst David Roman maintains Edwards Lifesciences with a Buy and raises the price target from $94 to $104.
Piper Sandler Reiterates Overweight on Edwards Lifesciences, Raises Price Target to $95
Piper Sandler analyst Adam Maeder reiterates Edwards Lifesciences with a Overweight and raises the price target from $90 to $95.
RBC Capital Maintains Outperform on Edwards Lifesciences, Raises Price Target to $95
RBC Capital analyst Shagun Singh maintains Edwards Lifesciences with a Outperform and raises the price target from $89 to $95.
Ações relacionadas
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.